These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23508836)

  • 1. Intracellular β2-adrenergic receptor signaling specificity in mouse skeletal muscle in response to single-dose β2-agonist clenbuterol treatment and acute exercise.
    Sato S; Shirato K; Mitsuhashi R; Inoue D; Kizaki T; Ohno H; Tachiyashiki K; Imaizumi K
    J Physiol Sci; 2013 May; 63(3):211-8. PubMed ID: 23508836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers.
    Lynch GS; Hayes A; Campbell SP; Williams DA
    J Appl Physiol (1985); 1996 Oct; 81(4):1610-8. PubMed ID: 8904577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling.
    Ngala RA; O'Dowd JF; Stocker CJ; Cawthorne MA; Arch JR
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Sep; 386(9):761-73. PubMed ID: 23564017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
    Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
    Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and physiologic characteristics of skeletal muscle determine its response to clenbuterol treatment.
    Sundal S; Katoch SS; Sharma S
    Indian J Biochem Biophys; 2006 Jun; 43(3):160-6. PubMed ID: 16967905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of beta(2)-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat.
    Ricart-Firinga C; Stevens L; Canu MH; Nemirovskaya TL; Mounier Y
    Am J Physiol Cell Physiol; 2000 Mar; 278(3):C582-8. PubMed ID: 10712247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles.
    Shi H; Zeng C; Ricome A; Hannon KM; Grant AL; Gerrard DE
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1681-9. PubMed ID: 17151143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of β-adrenergic stimulation and exercise on NR4A3 protein expression in rat skeletal muscle.
    Kawasaki E; Hokari F; Sasaki M; Sakai A; Koshinaka K; Kawanaka K
    J Physiol Sci; 2011 Jan; 61(1):1-11. PubMed ID: 20936441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of β-adrenergic signaling in PGC-1α-mediated adaptations in mouse skeletal muscle.
    Brandt N; Nielsen L; Thiellesen Buch B; Gudiksen A; Ringholm S; Hellsten Y; Bangsbo J; Pilegaard H
    Am J Physiol Endocrinol Metab; 2018 Jan; 314(1):E1-E20. PubMed ID: 28874356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol.
    Ryall JG; Gregorevic P; Plant DR; Sillence MN; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2002 Dec; 283(6):R1386-94. PubMed ID: 12388476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism.
    McCormick C; Alexandre L; Thompson J; Mutungi G
    J Appl Physiol (1985); 2010 Dec; 109(6):1716-27. PubMed ID: 20864554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
    Hayes A; Williams DA
    Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment.
    Lynch GS; Hinkle RT; Faulkner JA
    Exp Physiol; 2000 May; 85(3):295-9. PubMed ID: 10825417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive effects of the beta2-agonist clenbuterol on expression of beta2-adrenoceptor mRNA in rat fast-twitch fiber-rich muscles.
    Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
    J Physiol Sci; 2010 Mar; 60(2):119-27. PubMed ID: 20033361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course in calpain activity and autolysis in slow and fast skeletal muscle during clenbuterol treatment.
    Douillard A; Galbes O; Rossano B; Vernus B; Bonnieu A; Candau R; Py G
    Can J Physiol Pharmacol; 2011 Feb; 89(2):117-25. PubMed ID: 21326343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of phosphodiesterase 4 expression in the Epac1 signaling-dependent skeletal muscle hypertrophic action of clenbuterol.
    Ohnuki Y; Umeki D; Mototani Y; Shiozawa K; Nariyama M; Ito A; Kawamura N; Yagisawa Y; Jin H; Cai W; Suita K; Saeki Y; Fujita T; Ishikawa Y; Okumura S
    Physiol Rep; 2016 May; 4(10):. PubMed ID: 27207782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clenbuterol, a β2-adrenergic agonist, reciprocally alters PGC-1 alpha and RIP140 and reduces fatty acid and pyruvate oxidation in rat skeletal muscle.
    Hoshino D; Yoshida Y; Holloway GP; Lally J; Hatta H; Bonen A
    Am J Physiol Regul Integr Comp Physiol; 2012 Feb; 302(3):R373-84. PubMed ID: 22071161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice.
    Pellegrino MA; D'Antona G; Bortolotto S; Boschi F; Pastoris O; Bottinelli R; Polla B; Reggiani C
    Exp Physiol; 2004 Jan; 89(1):89-100. PubMed ID: 15109214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the beta 2-adrenergic agonist clenbuterol on the growth of fast- and slow-twitch skeletal muscle of the dystrophic (C57BL6J dy2J/dy2J) mouse.
    Agbenyega ET; Morton RH; Hatton PA; Wareham AC
    Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jul; 111(3):397-403. PubMed ID: 8564781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.